Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 2,013,000 | 3,406,000 | 2,611,000 | 2,138,000 | 2,492,000 |
Marketable Securities | 26,615,000 | 22,069,000 | 19,687,000 | 20,115,000 | 19,978,000 |
Receivables | 10,432,000 | 9,843,000 | 9,942,000 | 9,497,000 | 10,455,000 |
Inventories | 5,148,000 | 5,302,000 | 5,210,000 | 5,734,000 | 5,694,000 |
Other current assets | 864,000 | 731,000 | 641,000 | 574,000 | 487,000 |
TOTAL | $51,011,000 | $46,849,000 | $41,840,000 | $41,622,000 | $42,337,000 |
Non-Current Assets | |||||
PPE Net | 15,383,000 | 15,734,000 | 15,714,000 | 16,298,000 | 16,481,000 |
Investments And Advances | 4,511,000 | 4,856,000 | 4,922,000 | 5,067,000 | 4,817,000 |
Intangibles | 41,452,000 | 41,880,000 | 42,208,000 | 43,887,000 | 44,412,000 |
Other Non-Current Assets | 6,193,000 | 5,949,000 | 4,346,000 | 3,529,000 | 2,436,000 |
TOTAL | $67,539,000 | $68,419,000 | $67,190,000 | $68,781,000 | $68,146,000 |
Total Assets | $118,550,000 | $115,268,000 | $109,030,000 | $110,403,000 | $110,483,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 8,909,000 | 5,825,000 | 2,645,000 | 2,432,000 | 2,638,000 |
Accounts payable and accrued liabilities | 1,909,000 | 2,270,000 | 2,298,000 | 1,845,000 | 2,037,000 |
Accrued Expenses | 1,622,000 | 1,974,000 | 1,628,000 | 1,573,000 | 1,679,000 |
Other current liabilities | 8,020,000 | 8,223,000 | 7,489,000 | 6,760,000 | 6,412,000 |
TOTAL | $21,682,000 | $21,835,000 | $14,328,000 | $15,136,000 | $13,301,000 |
Non-Current Liabilities | |||||
Long Term Debt | 8,143,000 | 7,314,000 | 6,041,000 | 5,777,000 | 4,771,000 |
Other Non-Current Liabilities | 13,861,000 | 13,413,000 | 14,507,000 | 13,794,000 | 12,560,000 |
TOTAL | $29,451,000 | $28,423,000 | $28,092,000 | $27,173,000 | $24,694,000 |
Total Liabilities | $51,133,000 | $50,258,000 | $42,420,000 | $42,309,000 | $37,995,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 6,765,197 | 6,760,989 | 6,829,805 | 6,927,109 | 7,018,263 |
Common Shares | 443,000 | 442,000 | 442,000 | 442,000 | 441,000 |
Retained earnings | 52,436,000 | 49,660,000 | 51,063,000 | 50,304,000 | 53,063,000 |
Other shareholders' equity | 1,420,000 | 1,842,000 | -381,000 | -374,000 | -970,000 |
TOTAL | $67,417,000 | $65,010,000 | $66,610,000 | $68,094,000 | $72,488,000 |
Total Liabilities And Equity | $118,550,000 | $115,268,000 | $109,030,000 | $110,403,000 | $110,483,000 |